Steven Baughman v. Adrian Garcia

CourtCourt of Appeals for the Fifth Circuit
DecidedFebruary 25, 2019
Docket17-20435
StatusUnpublished

This text of Steven Baughman v. Adrian Garcia (Steven Baughman v. Adrian Garcia) is published on Counsel Stack Legal Research, covering Court of Appeals for the Fifth Circuit primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Steven Baughman v. Adrian Garcia, (5th Cir. 2019).

Opinion

Case: 17-20435 Document: 00514849161 Page: 1 Date Filed: 02/25/2019

IN THE UNITED STATES COURT OF APPEALS FOR THE FIFTH CIRCUIT United States Court of Appeals Fifth Circuit

No. 17-20435 FILED February 25, 2019 Lyle W. Cayce STEVEN KURT BAUGHMAN, Clerk

Plaintiff - Appellant

v.

DOCTOR MICHAEL SEALE; M. GUICE; DOCTOR LAMBI; DOCTOR HOWARD; DETENTION OFFICER J. RAMIREZ; DETENTION OFFICER M. Z. SACKS; DRAKE NARENDORF; NURSE SCOTT; KATHY ROSSI; EL FRANCO LEE; HARRIS COUNTY; BOBBY DAVIS,

Defendants - Appellees

Appeal from the United States District Court for the Southern District of Texas USDC No. 4:14-CV-3164

Before HIGGINBOTHAM, ELROD, and HO, Circuit Judges. PER CURIAM:* A parolee arrested and held in pretrial detainment brings this action alleging constitutional violations and torts arising from jail officials’ management of his diabetes, as well as alleged retaliation. The detainee appeals pro se the district court’s grant of summary judgment to the defendant

* Pursuant to 5TH CIR. R. 47.5, the court has determined that this opinion should not be published and is not precedent except under the limited circumstances set forth in 5TH CIR. R. 47.5.4. Case: 17-20435 Document: 00514849161 Page: 2 Date Filed: 02/25/2019

No. 17-20435 jail officials and to Harris County. We affirm the district court, deny the motion for appointment of counsel, and dismiss the case.

I. Steven Baughman is a pretrial detainee at the Harris County Jail, the third largest jail in the United States, housing almost 10,000 individuals. The Jail’s Health Services Division is responsible for Baughman’s medical care. The Division operates several clinics for specialized care, including a Chronic Care Clinic, which provides care for, among other conditions, type 2 diabetes. Baughman is among the Jail’s 105 to 120 inmates requiring care for diabetes. A. Type 2 diabetes is a disease of the endocrine system in which the pancreas does not produce adequate amounts of insulin, a hormone that lowers blood-glucose concentrations to maintain the normal range of 60 to 100 mg/dL. 1 When blood-glucose concentrations rise above this normal range, a person experiences a condition known as hyperglycemia, which can result in heart attack, stroke, loss of eyesight, kidney failure, diabetic coma, and death. A diabetic’s blood-glucose levels must be regulated by treatment, specifically, with injections of insulin or oral drugs such as metformin, glyburide, and glipizide. Diabetics often receive these drugs in connection with meals, when blood glucose is boosted by food consumption. While diabetic treatment is primarily aimed to prevent hyperglycemia, patients also must avoid excessively low levels of blood glucose. If concentrations fall below 60 mg/dL, a person experiences a condition known as hypoglycemia. Initially, hypoglycemia presents with sweatiness, jitters,

1 Baughman’s expert, Dr. David H. Madoff described the optimal fasting blood-glucose level as between 80 and 130 mg/dL. 2 Case: 17-20435 Document: 00514849161 Page: 3 Date Filed: 02/25/2019

No. 17-20435 fatigue, and dizziness. If left untreated, however, the situation can devolve into “severe hypoglycemia,” a situation in which the diabetic patient requires assistance. Untreated, it can result in disorientation, seizures, brain damage, and even coma or death. Hypoglycemia is affected by the patient’s balance of three variables: diet, specifically carbohydrate intake; physical activity; and drug dosage. If a patient’s blood-glucose level is unexpectedly low, a normal insulin dose can trigger hypoglycemia. So, diabetics often keep sugary foods or glucose tablets ready to hand, to raise blood-glucose levels if their treatment unexpectedly triggers hypoglycemia. To keep blood-glucose levels within the normal range, when diabetics use drugs like insulin they must know the status of their current blood-glucose levels, assessing the need for an increase or decrease. Many diabetics, particularly those who have lived with the condition for at least two years, have developed the ability to sense low blood-glucose levels, feeling telltale dizziness or shakiness. Where they feel these symptoms, diabetics may decline a scheduled insulin dose, so as not to lower blood-glucose levels, or they may consume a sugary food to raise blood-glucose levels into the normal range. While a diabetic may sense a low blood-glucose level, there are technologies that offer more precise measurement. One is the A1C hemoglobin test, a blood test which measures a patient’s average blood-glucose level over the preceding seven- to twelve-week period. Another method is the “fingerstick test,” a device which pricks the patient’s finger to draw a drop of blood, applies the blood to a test strip, and quantifies the current blood-glucose level. Outside jail, fingerstick tests are usually self-administered. Since blood-glucose levels can fluctuate, a combination of the A1C hemoglobin test and periodic fingerstick measurements allow a medical provider to define patterns of blood- glucose variability, and in light of these patterns adjust diabetes-drug regimens to keep a patient within the normal range. 3 Case: 17-20435 Document: 00514849161 Page: 4 Date Filed: 02/25/2019

No. 17-20435 More frequent measurement allows for a more detailed understanding of blood-glucose patterns. Accordingly, many professional sources recommend daily of use of blood-glucose tests. The Federal Bureau of Prisons’ Clinical Practice Guidelines states that “[f]requent monitoring of blood glucose (three times per day) is optimal for most patients with . . . type 2 diabetes who are on insulin.” The American Diabetes Association’s Position Statement on diabetes management in correctional institutions likewise insists that “[p]atients with type 2 diabetes need to monitor at least once daily, and more frequently based on their medical plan,” although “frequency of monitoring will vary by patients’ glycemic control and diabetes regimes.” The Institute for Clinical Systems Improvement, an organization that compiles medical care guidelines, recommends that “[p]atients using multiple insulin injections perform [self- monitoring of blood glucose] three or more times daily,” although it adds that frequent testing is particularly important where the patient is “using glucose to guide mealtime insulin dosing.” B. At the Harris County Jail, nurses circulate with an insulin cart to diabetic inmates’ cells twice a day, first around 3–4 a.m., and then again around 3–4 p.m. The carts carry insulin and oranges or apples, which are provided to inmates for consumption if they feel their glucose levels are too low. Though not on the carts, medical staff have glucose tablets for patients as needed. Another nurse circulates among the patients with a fingerstick testing device. Nurses administer insulin injections and undertake fingerstick testing as assigned by a list provided by the Jail’s licensed doctors and nurse practitioners (“medical providers”), specifying which patients are to receive which treatment or test on each round. The Jail has no universal requirement regarding the frequency of fingerstick testing. The frequency of testing is governed in the first instance by 4 Case: 17-20435 Document: 00514849161 Page: 5 Date Filed: 02/25/2019

No. 17-20435 the medical provider’s clinical judgment as to a patient’s needs, although as will be seen, this judgment is not the final word. The Jail’s former Executive Medical Director, Dr. Michael Seale, and its current interim Executive Medical Director, Dr. Marcus Guice, concede that the Jail’s delegation of fingerstick testing frequency to medical providers can—and does—result in less frequent testing than recommended by the Federal Bureau of Prisons, American Diabetes Association, and Institute for Clinical Systems Improvement.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Hare v. City of Corinth, Miss.
74 F.3d 633 (Fifth Circuit, 1996)
Domino v. Texas Department of Criminal Justice
239 F.3d 752 (Fifth Circuit, 2001)
Gibbs v. Grimmette
254 F.3d 545 (Fifth Circuit, 2001)
Harlow v. Fitzgerald
457 U.S. 800 (Supreme Court, 1982)
Anderson v. Liberty Lobby, Inc.
477 U.S. 242 (Supreme Court, 1986)
Claude E. Woods v. Larry Smith
60 F.3d 1161 (Fifth Circuit, 1995)
Perez v. Johnson
122 F.3d 1067 (Fifth Circuit, 1997)
Farmer v. Brennan
511 U.S. 825 (Supreme Court, 1994)
Texas Department of Criminal Justice v. Miller
51 S.W.3d 583 (Texas Supreme Court, 2001)
Cary King v. Louisiana Tax Commission
821 F.3d 650 (Fifth Circuit, 2016)
Mary Smith v. Regional Transit Authority, e
827 F.3d 412 (Fifth Circuit, 2016)
Jonathan Davidson v. City of Stafford, Texas, et a
848 F.3d 384 (Fifth Circuit, 2017)

Cite This Page — Counsel Stack

Bluebook (online)
Steven Baughman v. Adrian Garcia, Counsel Stack Legal Research, https://law.counselstack.com/opinion/steven-baughman-v-adrian-garcia-ca5-2019.